Literature DB >> 32438074

Therapeutic Vaccines for the Treatment of HIV.

Zhilin Chen1, Boris Julg2.   

Abstract

Despite the success of anti-retroviral therapy (ART) in transforming HIV into a manageable disease, it has become evident that long-term ART will not eliminate the HIV reservoir and cure the infection. Alternative strategies to eradicate HIV infection, or at least induce a state of viral control and drug-free remission are therefore needed. Therapeutic vaccination aims to induce or enhance immunity to alter the course of a disease. In this review we provide an overview of the current state of therapeutic HIV vaccine research and summarize the obstacles that the field faces while highlighting potential ways forward for a strategy to cure HIV infection.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive immune responses; HIV; HIV cure; Therapeutic vaccination

Mesh:

Substances:

Year:  2020        PMID: 32438074      PMCID: PMC8188575          DOI: 10.1016/j.trsl.2020.04.008

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  129 in total

1.  Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals.

Authors:  Yves Lévy; Christine Durier; Anne-Sophie Lascaux; Vincent Meiffrédy; Hanne Gahéry-Ségard; Cécile Goujard; Christine Rouzioux; Martine Resch; Jean-Gérard Guillet; Michel Kazatchkine; Jean-François Delfraissy; Jean-Pierre Aboulker
Journal:  AIDS       Date:  2006-02-14       Impact factor: 4.177

Review 2.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

3.  Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival.

Authors:  Emmanuel S Antonarakis; Eric J Small; Daniel P Petrylak; David I Quinn; Adam S Kibel; Nancy N Chang; Erica Dearstyne; Matt Harmon; Dwayne Campogan; Heather Haynes; Tuyen Vu; Nadeem A Sheikh; Charles G Drake
Journal:  Clin Cancer Res       Date:  2018-06-01       Impact factor: 12.531

Review 4.  Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials.

Authors:  Tomáš Hanke
Journal:  Expert Rev Vaccines       Date:  2019-10-15       Impact factor: 5.217

5.  Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.

Authors:  Joseph P Casazza; Kathryn A Bowman; Selorm Adzaku; Emily C Smith; Mary E Enama; Robert T Bailer; David A Price; Emma Gostick; Ingelise J Gordon; David R Ambrozak; Martha C Nason; Mario Roederer; Charla A Andrews; Frank M Maldarelli; Ann Wiegand; Mary F Kearney; Deborah Persaud; Carrie Ziemniak; Raphael Gottardo; Julie E Ledgerwood; Barney S Graham; Richard A Koup
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

6.  Portable flanking sequences modulate CTL epitope processing.

Authors:  Sylvie Le Gall; Pamela Stamegna; Bruce D Walker
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).

Authors:  Dan H Barouch; Frank L Tomaka; Frank Wegmann; Daniel J Stieh; Galit Alter; Merlin L Robb; Nelson L Michael; Lauren Peter; Joseph P Nkolola; Erica N Borducchi; Abishek Chandrashekar; David Jetton; Kathryn E Stephenson; Wenjun Li; Bette Korber; Georgia D Tomaras; David C Montefiori; Glenda Gray; Nicole Frahm; M Juliana McElrath; Lindsey Baden; Jennifer Johnson; Julia Hutter; Edith Swann; Etienne Karita; Hannah Kibuuka; Juliet Mpendo; Nigel Garrett; Kathy Mngadi; Kundai Chinyenze; Frances Priddy; Erica Lazarus; Fatima Laher; Sorachai Nitayapan; Punnee Pitisuttithum; Stephan Bart; Thomas Campbell; Robert Feldman; Gregg Lucksinger; Caroline Borremans; Katleen Callewaert; Raphaele Roten; Jerald Sadoff; Lorenz Scheppler; Mo Weijtens; Karin Feddes-de Boer; Daniëlle van Manen; Jessica Vreugdenhil; Roland Zahn; Ludo Lavreys; Steven Nijs; Jeroen Tolboom; Jenny Hendriks; Zelda Euler; Maria G Pau; Hanneke Schuitemaker
Journal:  Lancet       Date:  2018-07-06       Impact factor: 79.321

8.  Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab.

Authors:  Carla Serra-Peinado; Judith Grau-Expósito; Laura Luque-Ballesteros; Antonio Astorga-Gamaza; Jordi Navarro; Jenny Gallego-Rodriguez; Mario Martin; Adrià Curran; Joaquin Burgos; Esteban Ribera; Berta Raventós; Rein Willekens; Ariadna Torrella; Bibiana Planas; Rosa Badía; Felipe Garcia; Josep Castellví; Meritxell Genescà; Vicenç Falcó; Maria J Buzon
Journal:  Nat Commun       Date:  2019-08-16       Impact factor: 14.919

9.  Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.

Authors:  Concepcion Casado; Cristina Galvez; Maria Pernas; Laura Tarancon-Diez; Carmen Rodriguez; Víctor Sanchez-Merino; Mar Vera; Isabel Olivares; Rebeca De Pablo-Bernal; Alberto Merino-Mansilla; Jorge Del Romero; Ramon Lorenzo-Redondo; Ezequiel Ruiz-Mateos; María Salgado; Javier Martinez-Picado; Cecilio Lopez-Galindez
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

10.  Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope.

Authors:  Keri L Schaubert; David A Price; Nicole Frahm; Jinzhu Li; Hwee L Ng; Aviva Joseph; Elyse Paul; Biswanath Majumder; Velpandi Ayyavoo; Emma Gostick; Sharon Adams; Francesco M Marincola; Andrew K Sewell; Marcus Altfeld; Jason M Brenchley; Daniel C Douek; Otto O Yang; Christian Brander; Harris Goldstein; June Kan-Mitchell
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

View more
  2 in total

1.  Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques.

Authors:  Antonio Valentin; Cristina Bergamaschi; Margherita Rosati; Matthew Angel; Robert Burns; Mahesh Agarwal; Janina Gergen; Benjamin Petsch; Lidia Oostvogels; Edde Loeliger; Kara W Chew; Steven G Deeks; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 2.  Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure.

Authors:  Stella J Berendam; Ashley N Nelson; Bhrugu Yagnik; Ria Goswami; Tiffany M Styles; Margaret A Neja; Caroline T Phan; Sedem Dankwa; Alliyah U Byrd; Carolina Garrido; Rama R Amara; Ann Chahroudi; Sallie R Permar; Genevieve G Fouda
Journal:  Front Immunol       Date:  2022-07-13       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.